Elevated DHEA Level of 377 µg/dL in a Female
An elevated DHEA level of 377 µg/dL in a female is moderately elevated but does not reach the critical threshold of 600 µg/dL that would indicate an adrenal tumor requiring urgent imaging. This level most commonly suggests polycystic ovary syndrome (PCOS) with adrenal androgen excess, though other causes must be systematically excluded 1.
Clinical Significance and Interpretation
DHEA (dehydroepiandrosterone) and its sulfate form DHEAS are primarily produced by the adrenal cortex and serve as markers of adrenal androgen production. A level of 377 µg/dL falls into the moderately elevated range:
- Critical threshold: DHEAS >600 µg/dL suggests adrenal cortical adenoma (often with hypercorticism) and mandates urgent abdominal CT or MRI 1
- Your patient's level (377 µg/dL): Indicates adrenal androgen excess but below the tumor threshold
Approximately 20-30% of PCOS women demonstrate excess adrenal androgen production, and elevated DHEAS is found in 60% of hirsute women 2, 3. Importantly, 77% of women with elevated DHEAS are non-hirsute, so absence of hirsutism does not exclude hyperandrogenism 4.
Systematic Evaluation Algorithm
Step 1: Measure Complementary Androgens
Check early morning (before 10 AM) total testosterone and free testosterone 5:
- If testosterone is >2× upper limit of normal, this increases concern for ovarian hyperthecosis or androgen-secreting ovarian tumor
- DHEAS elevation combined with testosterone elevation suggests generalized hyperandrogenism rather than isolated adrenal excess 1
Step 2: Exclude Life-Threatening Causes
Even at this moderate DHEAS level, systematically rule out:
- Pregnancy test if amenorrheic
- Pelvic ultrasonography to detect ovarian neoplasm or polycystic ovaries
- 17-hydroxyprogesterone (early morning, follicular phase) if high-risk ethnicity (Ashkenazi Jewish, Hispanic, Slavic) or family history suggests congenital adrenal hyperplasia 5
- Prolactin level to exclude hyperprolactinemia
- Clinical assessment for Cushing's syndrome (central obesity, striae, moon facies), thyroid dysfunction, or acromegaly if suggestive features present 5
Step 3: Assess for PCOS
Look for the following features that increase likelihood of PCOS 5:
- Menstrual irregularity or anovulation
- Clinical hyperandrogenism (hirsutism, acne, seborrhea, androgenic alopecia)
- Central obesity
- Acanthosis nigricans
- Family history of type 2 diabetes
- Insulin resistance markers
PCOS is the most common cause of this presentation, accounting for the majority of moderate DHEAS elevations in reproductive-age women 2.
Step 4: Consider Medication History
Obtain detailed medication history:
- Valproic acid is the only anticonvulsant that raises testosterone levels 5
- Androgenic medications (anabolic steroids, danazol)
- Medications with estrogenic effects that alter SHBG (certain antiepileptics)
Additional Diagnostic Considerations
If initial workup is negative but clinical suspicion remains high:
- Androstenedione levels may provide additional information 1
- SHBG measurement helps interpret total testosterone (typically reduced in obesity, metabolic syndrome) 1
- Dexamethasone suppression testing can help differentiate adrenal from ovarian sources 1, 6
- ACTH stimulation test may reveal exaggerated adrenal response (34% of patients with elevated DHEAS show this pattern) 4
Important Caveats
Age matters significantly: DHEAS values decline by approximately 40% from the twenties to thirties, so interpretation must be age-adjusted 7. Younger women (20-29 years) with PCOS show higher prevalence of elevated DHEAS, particularly in non-classic PCOS phenotypes (B and C) 7.
Timing of testing: Measure androgens in early morning during follicular phase (days 4-10) in regularly cycling women, as this is when norms are standardized 1, 5.
Common pitfall: Do not assume normal testosterone excludes significant pathology. Some women have isolated DHEAS elevation, and approximately 7.7% have elevated DHEA with normal testosterone 6.
Clinical Implications for Morbidity and Mortality
While this DHEAS level doesn't suggest immediate life-threatening pathology, failure to diagnose underlying PCOS carries significant long-term risks including:
- Type 2 diabetes mellitus
- Cardiovascular disease
- Endometrial hyperplasia/cancer (from chronic anovulation)
- Infertility
Paradoxically, elevated DHEAS may be protective against cardiovascular risk in the general population, though this relationship in PCOS remains unclear 2.